{Reference Type}: Journal Article
{Title}: An ULK1/2-PXN mechanotransduction pathway suppresses breast cancer cell migration.
{Author}: Liang P;Zhang J;Wu Y;Zheng S;Xu Z;Yang S;Wang J;Ma S;Xiao L;Hu T;Jiang W;Huang C;Xing Q;Kundu M;Wang B;
{Journal}: EMBO Rep
{Volume}: 24
{Issue}: 11
{Year}: 2023 11 6
{Factor}: 9.071
{DOI}: 10.15252/embr.202356850
{Abstract}: The remodeling and stiffening of the extracellular matrix (ECM) is a well-recognized modulator of breast cancer progression. How changes in the mechanical properties of the ECM are converted into biochemical signals that direct tumor cell migration and metastasis remain poorly characterized. Here, we describe a new role for the autophagy-inducing serine/threonine kinases ULK1 and ULK2 in mechanotransduction. We show that ULK1/2 activity inhibits the assembly of actin stress fibers and focal adhesions (FAs) and as a consequence impedes cell contraction and migration, independent of its role in autophagy. Mechanistically, we identify PXN/paxillin, a key component of the mechanotransducing machinery, as a direct binding partner and substrate of ULK1/2. ULK-mediated phosphorylation of PXN at S32 and S119 weakens homotypic interactions and liquid-liquid phase separation of PXN, impairing FA assembly, which in turn alters the mechanical properties of breast cancer cells and their response to mechanical stimuli. ULK1/2 and the well-characterized PXN regulator, FAK/Src, have opposing functions on mechanotransduction and compete for phosphorylation of adjacent serine and tyrosine residues. Taken together, our study reveals ULK1/2 as important regulator of PXN-dependent mechanotransduction.